Pelvic floor therapies after surgery for gynaecological cancer: a telehealth intervention trial

Not Applicable

Completed

• Conditions: Pelvic floor dysfunction; gynaecological cancer; Renal and Urogenital - Other renal and urogenital disorders; Cancer - Cervical (cervix); Cancer - Womb (Uterine or endometrial cancer); Cancer - Ovarian and primary peritoneal

• Registration Number: ACTRN12621000880842
• Lead Sponsor: niversity of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-08
• Study Completion: 2022-12-16
• Last Update Posted: 13 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 36

Inclusion Criteria

Women who have had surgery for primary gynaecological treatment for uterine, endometrial, cervical or ovarian cancer, based on oncology assessment, or a histologically confirmed uterine, endometrial, cervical or ovarian tumour, International Federation of Gynecology and Obstetrics (FIGO) cancer staging system classification stages I-III (if known); have any type of urinary and/or faecal incontinence, have an Eastern Cooperative Oncology Group performance status of between 0-2 (with a score of 0 being fully active to and a score of 2 being resting in bed less than 50% of the day); have the capability and access to use a telecommunication platform in their own home; have sufficient English language skills to participate; and are at least 18 years of age.

Exclusion Criteria

Women with a FIGO cancer staging system classification stage IV, who are pregnant, up to 12 months postnatal or who are breastfeeding, have neurological disorders or severe physical/psychiatric impairments, or who have, within the last 2 years, received physiotherapist-supervised PFMT or pelvic surgery for incontinence or pelvic organ prolapse will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified